Rev Esp Quimioter 2023; 36(6): 658-660

Update on Bimervax® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)

CRISTINA BORRALLERAS, JAVIER CASTRODEZA SANZ, PILAR ARRAZOLA, CARMEN CÁMARA HIJÓN, JOSÉ Mª EIROS, MARÍA FERNÁNDEZ-PRADA, ÁNGEL GIL DE MIGUEL, GLORIA MIRADA MASIP, FERNANDO MORAGA-LLOP, DANIEL OCAÑA RODRÍGUEZ, JOAN PUIG-BARBERÀ, JORGE VÁZQUEZ, JÚLIA VERGARA-ALERT, SALOMÉ DE CAMBRA

Published: 8 September 2023

LETTER TO THE EDITOR

http://www.doi.org/10.37201/req/085.2023

Rev Esp Quimioter 2023; 36(6): 658-660  [Full-text PDF]